GeneLeap

We are excited to be attending #PMWC25 next week at the Santa Clara Convention Center! Mark you calendars for the talk by our CEO and founder: Leveraging Genomics and AI to Personalize Drug Therapy Fri Feb 7 | 9:15 - 9:30 AM | Showcase Track S1 Tod M Klingler PhD PMWC - Precision Medicine World Conference

Untreated mental health conditions, particularly depression, costs the global economy $1 trillion annually in lost productivity and healthcare expenses. At GeneLeap, we're revolutionizing mental health treatment through our AI-powered pharmacogenomic platform. We are developing a system that uses individual genetic profiles to optimize antidepressant recommendations and eliminate the traditional trial-and-error approach. Our solution will promise better patient outcomes while reducing healthcare costs through personalized treatment plans. Learn more about the economic impact of mental health and the potential of precision medicine in this insightful Financial Times article:?https://lnkd.in/grhJGswA #MentalHealth #PrecisionMedicine #GeneLeap #Pharmacogenomics #EconomicImpact

???The future of depression treatment is personalized. Traditional prescribing practices often leave patients cycling through medications for months or years. At GeneLeap, we're leveraging genetic insights and AI to match patients with the right treatment from day one. Read our Head of UX's deep dive into why this matters and how we're making it happen:?https://lnkd.in/gscPqkDh #Depression #PersonalizedMedicine #AI #BioTech

As Thanksgiving approaches, we are reminded that while this time of year brings joy for many, it can also be a period of heightened stress and depression for others. At GeneLeap, we understand that finding the right treatment for depression can be a long and frustrating journey. In fact, only 30% of patients respond fully to their first antidepressant, and many face a trial-and-error process that can take months or even years to find relief. This challenge is often exacerbated during the holiday season, when social pressures and expectations can intensify feelings of isolation and anxiety. This Thanksgiving, we are committed to changing that narrative. By leveraging generative AI and genetic profiling, GeneLeap is working to revolutionize how depression is treated—helping patients receive personalized treatment recommendations based on their unique genetic makeup. Our goal is to eliminate the guesswork in prescribing antidepressants, allowing individuals to find effective treatments faster and with fewer side effects. As we gather with loved ones or reflect on the year, let’s also remember those who may be struggling silently. If you or someone you know is experiencing depression or anxiety this holiday season, seeking the right support is crucial. At GeneLeap, we're here to help make that journey easier and more effective. If you need immediate support, we recommend reaching out to the National Alliance on Mental Illness (NAMI) Helpline at?https://lnkd.in/gfcV5-Xz?for compassionate guidance and resources. #MentalHealth #Thanksgiving #DepressionAwareness #PrecisionMedicine #GeneLeap

???? California Invests in Precision Medicine for Mental Health Exciting news! California is investing in precision medicine research for depression, recognizing its potential to transform mental health care. This move validates the growing importance of personalized approaches in addressing mental health challenges. At GeneLeap, we're proud to be at the forefront of this movement. We are building a platform to help providers prescribe the most effective treatments based on each patient's unique genetic profile, aiming to reduce suffering and improve outcomes. The future of mental health care is here, and it's precise, effective, and compassionate. ?? Learn more:?https://lnkd.in/gZzjHJsF #PrecisionMedicine #MentalHealth #CaliforniaInnovation #GeneLeap #FutureOfHealthcare

??????????? ?????????? ?????? ???????? ???? ?????????? ?????? ???????????? ???? ???????????????????? ?????????????????? ?? For many, the journey to find the right medication for depression feels like a therapeutic odyssey—one that can involve months or even years of trial and error. This journey impacts not only mental health but also overall quality of life, often leaving individuals and their loved ones feeling discouraged or overwhelmed. At GeneLeap, we’re working to transform this process. Our platform aims to use genetic insights to find the right treatment faster, so patients can move beyond the trial-and-error phase and find relief from the very start. But to make this vision a reality, we need your help. If you’ve experienced the challenges of finding an effective medication for depression, or if you have insights from supporting a friend or loved one through this process, we’d be incredibly grateful if you’d share your story with us.?Your story can remain anonymous?and will provide invaluable insights into the realities of navigating depression treatment. Join us in shaping a future where the therapeutic journey is shorter, more personalized, and more effective for everyone. ?? ?? Share your story to help shape the future of depression treatment by completing our form [link below]. https://lnkd.in/gJydbu8z #GeneLeap #TherapeuticOdysseys #DepressionTreatment #MentalHealthInnovation

If you missed some of the discussion around the recent Nobel Prizes,

On this World Mental Health Day, we at GeneLeap affirm our commitment to improving mental health outcomes for all. Our passion lies in leveraging cutting-edge biomedical and information technologies to transform lives. Our focus is clear: patients and their providers come first. We identify critical challenges in medicine that can be addressed through innovative science and technology. We are tackling the often lengthy trial-and-error process in prescribing antidepressants. The platform we are building aims to significantly reduce the "therapeutic odyssey,” which often lasts 6 months or more, in order to get patients effective treatments faster, potentially from the very first prescription. Together, we can make a difference in mental health care. Let's continue this important conversation. #WorldMentalHealthDay #TherapeuticOdysseys #HealthandWellness #MentalHealthInnovation

We're excited?to be launching our company out of stealth mode and sharing our vision for improving lives?using innovations built from the latest advances in biomedical and information technologies. We're grateful for the ideation and technological foundation we've received from Leap AI, and we're looking forward to their continued support as we grow as a company! #TreatmentOptimization #LeapAI #Genomics #GenerativeAI